QureTech Bio

Quretech Bio - defeats bacterial virulence

Since World War II, antibiotics have been the most effective factor in longevity and population expansion. Today, loss of effective antibiotics threatens our medical institutions – antibiotic resistance is a serious problem already or will be within the decade. Doctors, in the US and UK, have reported that they now have less than a handful effective antibiotics for some pathogens. In the EU alone, infections with multidrug resistant bacteria cause around 25,000 deaths each year and the associated economic burden is immense. Still in today’s world, more infants and children are dying from pneumonia than from malaria.

QureTech Bio’s vision is to develop first line drugs to combat antibiotic resistance and infectious diseases. The global market for antibiotics is estimated at USD 38 billion with USA, Europe and Japan representing 50%. The cost of antibiotic resistance to medical communities in the EU alone is conservatively estimated to be €1.5 billion and the availability of new targeted antibiotics of this type would generate significant cost savings for healthcare systems.

New types of antibiotics to tackle resistant bacteria are urgently needed, yet there is an almost empty drug pipeline with few early stage drugs under development. Scientific and industrial communities must develop new antibiotic drugs, and there must be a drive towards developing novel antibiotics with alternative modes of action.


Current projects

CEO Fritiof Pontén presenting at Park Annual 2016 ... See MoreSee Less

View on Facebook

World antibiotic day today! :-)
Acknowledge and respect the antibiotics, they are fantastic drugs. But take a moment to this film and understand the risks associated with broad spectrum antibiotics. Every treatment comes with a risk and by overuse we expose ourselves to those risks.
QureTech Bio mitigates this risks by developing a highly selective treatment for Chlamydia infection. The drug only affect the bacteria, Chlamydia trachomatis, and thus the "good" bugs are saved and can continue to fight the bad ones like Clostridium difficile mentioned in the film.
... See MoreSee Less

The benefits of antibiotics are well known, but the risks are not. In this video, Christian Lillis, son of Peggy Lillis, shares his personal story of losing his mother to a Clostridium difficile infection (C. difficile) caused by antibiotic use. bit.ly/2g54WBF

View on Facebook